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ABSTRACT
WILLIAM HAMILTON LOWRY. Retrospectively Assigning Context of Observation
for F-344 Rats Chronically Exposed to Formaldehyde. (Under the Direction of
ALVIS G. TURNER)
One approach to estimating age-specific tumor incidence rates using
scheduled sacrifice information involves determining context of observation for
each tumor bearing animal. Context of observation is defined as determination
of whether the tumor of interest contributed directly or indirectly to the cause of
death, or alternatively, the tumor was an incidental finding at necropsy, in an
animal dying of an unrelated cause. The present study was undertaken to
assign retrospectively the context of observation for nasal squamous cell
carcinoma in F-344 rats exposed to 15 ppm of formaldehyde for up to 24
months. Results indicate that greater than 90% of the tumors were classifiable
as definitely incidental (2%) or definitely fatal (88%) with a high degree of
confidence. This study demonstrates that context of observation can be
assigned even long after the bioassay has been completed, provided the data
have been properly archived.
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LITERATURE REVIEW
Regulatory History
In 1946, the American Conference of Governmental Industrial Hygenists
(ACGIH) set the threshold limit value (TLV) for formaldehyde at 10 parts per
million (ppm). Responding to reports documenting formaldehyde as an irritant,
the ACGIH reduced the TLV to 5 ppm in 1948. In 1970, this TLV was adopted
under the Construction Safety Act and incorporated in the Occupational Safety
and Health Administration (OSHA) construction standards. However, complaints
of irritation at concentrations far below this ceiling forced the ACGIH to further
reduce the ceiling limit to 2 ppm (Federal Register, 1987).
The National Institute of Occupational Safety and Health (NIOSH) in 1976
recommended that OSHA reduce the permissible exposure limit (PEL)
measured over a period of 30 minutes to 1 ppm. This recommendation was
based on reports of eye, skin, and respiratory irritation experienced by a few
workers at 0.3 ppm and widespread complaints at levels exceeding 1 ppm
(Federal Register, 1987).
During the year of 1976, the Consumer Product Safety Commission (CPSC)
received numerous reports from individuals complaining of adverse health
effects from formaldehyde exposure. As a result, the National Research
Council's Committee on Toxicology was asked to evaluate the literature and
adetermine safe concentrations from long-term continuous exposure in the home.
Based on available data, the Committee concluded that there was no human
population threshold for the irritant effects of formaldehyde, even at extremely
low airborne concentrations (NAS 1980).   Regarding formaldehyde
carcinogenicity, the Committee prefaced their report by stating:
"It must be recognized that the concern and
deliberations that led to development of this
document have to a certain extent been
superseded by the recent preliminary report
from the Chemical Industry Institute of
Toxicology (CUT), which indicated that
formaldehyde exposure induced nasopharyngeal
carcinomas in rats. It is strongly recommended
that when the CUT study has been reported in
detail, and the results are available for
evaluation, an appropriate peer group should
review in detail and comment on the
investigation..." (NAS 1980).
In October of 1979, CUT responded to reporting requirements established
by section 8(e) of the Toxic Substances Control Act (TSCA). The Environmental
Protection Agency (EPA), who enforces TSCA, was sent the preliminary findings
of the animal bioassy indicating squamous cell carcinoma in rats exposed to
formaldehyde concentrations of 14.3 ppm at interim sacrifices. The study was
completed in 1981 and results indicated nasal cancers in rats exposed to
concentrations of 14.3 and 5.6 ppm and in mice exposed to 14.3 ppm. This
evidence was corroborated by a study at New York University (NYU) that also
found nasal cancers in rats at 14 ppm (Federal Register, 1987). I
In 1980, the Federal Panel on Formaldehyde, consisting of scientists from
eight federal agencies, evaluated the existing data and concluded that it was
"prudent to regard formaldehyde as posing a carcinogenic risk to humans"
(Federal Register, 1987). Based on the CUT and NYU studies along with the
Federal panel's conclusion, NIOSH in 1981 classified formaldehyde as a
potential occupational carcinogen.
In 1982, the CPSC used the CUT data, coupled with consumer complaint
data, to ban urea-formaldehyde foam insulation (UFFI) in homes and schools.
However, this ruling was overturned in subsequent litigation (Gulf South
insulation v. CPSC, 701 F. 2d 1137 5th cir. 1983) because of unsubstantiated
evidence. The court faulted CPSC for relying solely on the data of the CUT study
in establishing a risk estimate for consumers. Also, the Court determined that
consumer complaint data were not an acceptable method for determining the
risk of injury due to the effects of an acute irritant (701 F.2nd at 1148).
In 1983, the ACGIH added formaldehyde to the list of industrial substances
suspected of causing cancer in humans and reduced the Threshold Limit Value
fTLV) to 1 ppm, measured as an 8 hour time weighted average (TWA). ACGIH
also set the short-term exposure limit (STEL) for formaldehyde at 2 fSpm
(Federal Register, 1987). Also in 1983, the National Center for Toxicological
Research (NCTR) sponsored a workshop on formaldehyde to try to resolve the
controversies surrounding formaldehyde's acute and chronic health effects.
Scientific studies were reviewed by over 60 scientists from government, industry
and universities. A risk estimation panel attempted to develop a risk assessment
for humans exposed to formaldehyde. They concluded that carcinogenicity was
the only end point that could be assessed quantitatively. The panel also
concluded that the modeling for carcinogenicity should be based on the CUT
study instead of human epidemiology studies that did not provide adequate
evidence for carcinogenicity (Federal Register, 1987).
The Department of Housing and Urban Development (HUD) in February of
1985 designated standards for off-gassing of formaldehyde from pressed wood
products used to produce manufactured and mobile homes. These regulations
prohibit the emissions of formaldehyde from plywood and particieboard which
would result in an air concentration in excess of 0.2 ppm and 0.3 ppm,
respectively (Federal Register, 1987). One year later, the EPA announced it
would relinquish its authority to regulate formaldehyde in occupational exposure
settings because of OSHA's jurisdiction in that area. However, EPA would
continue to investigate non occupational situations, such as those settings which^
used pressed wood products made with formaldehyde-based resins. In April of
1987, EPA published their assessment of health risks associated with
formaldehyde exposure. Their position states that formaldehyde should be
classified as a "group B1 probable human carcinogen," based on 1)"sufficifent"
e^/'dence that formaldehyde is an animal carcinogen, 2) "limited" evidence from
human studies, and 3) other information, including short-term tests, (ie. gene
mutation, sister chromatid exchanges, and chromosome abberation),
pliarmacokinetic studies, (DNA-protein crosslinks in the nose of rats exposed to
> 2 ppm) and comparative metabolism studies, (showing non-linear increases
in covalent binding at higher concentrations) (Nelson at al., 1986). EPA's
"limited" (a causal interpretation is credible) evidence from human studies is
based on nine epidemiologic studies, but because of possible exposure to other
agents, the findings could have been confounded (Federal Register, 1987). in
1988, an Ad Hoc Panel on Health Aspects of Formaldehyde, composed of
independent, international scientists, evaluated the existing literature and
concluded that: 1) for no malignancy in man is there convincing evidence of a
relationship with formaldehyde exposure and 2) if a relationship does exist, the
excess risk, in absolute terms, must be small. The panel futher stated that the
apparent lack of consistency in studies of site-specific cancer risk, and the
uncertainty resulting from unresolved confounding by known risk factors,
prevented the panel from making more definitive conclusions (Universities
Associated for Research and Education in Pathology, Inc., 1988). ;
A working group from the International Agency for Research on Cancer
(lARC) in 1987 reviewed recent epidemiological evidence on formaldehyde and
upgraded their designation to category 2(A), a probable human carcinogen.
OSHA promulgated the final rule for occupational exposure to formaldehyde
published in the Federal Register dated December 4,1987 in 29 CFR Parts 1910
and 1926. This standard reduced the permissible exposure level (PEL) from 3
ppm of formaldehyde in air to 1 ppm as an 6 hour TWA, and reduced the 15
minute short term exposure limit (STEL) from 5 ppm to 2 ppm. OSHA also at
this time revoked the peak allowable exposure of 10 ppm and included an
"action level" of 0.5 ppm measured as an 8-hour TWA to reduce the compliance
burden for employers whose employees have minimal exposure to
6formaldehyde. This standard took effect on February 2, 1988 (Federal Register,
1987).
Physical and Chemical Properties of Formaldehyde
Formaldehyde is defined as the chemical entity HCHO, and is identified by
the Chemical Abstracts Service Registry No. 50-00-0. Formaldehyde is a
colorless gas that boils at -19" C upon condensing and freezes at -118° C.
Because of this chemical's ability to polymerize so readily, it is sold or
transported in solution. Formalin is the most frequently encountered solution,
containing 37-50 per cent formaldehyde and 6-15 per cent alcohol stabilizer,
usually in the form of methanol (Nelson at al. 1986). Paraformaldehyde occurs
as a solid polymer that vaporizes to its monomeric form and can contribute as a
sourca of formaldehyde gas. Pure forms of formaldehyde gas are stable at
temperatures between 80° and 100° C, however stability Is dependent upon
purity and even water will enhance the rate of polymerization (Federal Register,^
1987). 'I
One molecule of formaldehyde consists of a single carbonyl group with two
atoms of hydrogen, H2C = 0. Most reactions (Nelson et al., 1986) fall into the
following three reaction sequences:
OXIDATION-REDUCTION
Cannizarro Reaction
2HCH0 ---- HCOOH + CHgOH
ADDITION OR CONDENSATION
o
+   HCHO
Bisulfite Addition:
HCHO + NaHSOg -
Aldol Condensation:
HCO + R'(R")CHC = OR
POLYMERIZATION
Methylol Formation:
OH
:h20h -
HOCHgSOgNa
HOCHCR'(R")C=OR
o
OH
o
CHjO
Production and Use of Formaldehyde
Formaldehyde was first produced in the United States In 1901. It is now
ranked 24th in production volume in the United States, with 5.7 billion pounds
produced in 1985 (Federal Register, 1987). Formaldehyde is produced using
two processes: the mixed oxide catalyst process or the silver oxide catalyst
process. While both of these processes require methanol as the precursor, the
processes differ In catalyst type, operating temperatures, and methanol/air
ratios. Because of formaldehyde's high degree of chemical reactivity, It re^ily
undergoes a wide variety of chemical reactions, as previously mentioned.
Addition or condensation reactions are of great commercial value, for these
reaction yield such products as pentaerythritol and hexamethylenetetramine,
v^hich are used in the wood product and apparell manufacturing industries
respectively. However, methanol formation Is the most important commercial
reaction because the derivatives are used as the starting point in resin
production (Federal Register, 1987).
8The manufacture of resins such as urea-formaldehyde, phenol-
formaldehyde, and melamine formaldehyde comprise 59% of the total
consumption of formaldehyde. Approximately 33% is used in the synthesis of
such chemicals as pentaerythritol, hexamethylenetetramine, and butanediol.
Two percent is consumed in the treatment of textiles, while small amounts are
used in consumer and industrial products such as cosmetics, shampoo, glue,
and preservatives (Federal Register, 1987).
Urea-formaldehyde resins represent an entire class of resins formulated by
polymerizing different ratios of urea and formaldehyde at different pH levels and
combining such additives as thickeners, hardeners, plasticizers, and curing
agents. Greater than half of the urea-formaldehyde resins produced are used as
adhesives in the manufacture of particleboard and plywood. Urea-formaldehyde
foam insulation (UFFI) was a resin made from urea, water, and formaldehyde
that was mixed on site and pumped, using a propellant, Into both commercial
and residential building (Federal Register, 1987).
Phenol-formaldehyde resins are produced by the condensation reaction of
methylol derivatives and are used primarily as binders for softwood plywoods.
They are also used in the production of compounds of plastic molds, insulation,
and abrasives. Polyacetal resins and melamine-formaldehyde resins are used
in plastic molded compounds such as plates and cups, buttons, and decorative
laminates used in furniture (Federal Register, 1987).
Nelson et al. (1986) report a number of other uses of formaldehyde
including the manufacture of rubber, photographic film, leather, explosives,
9dyes, cosmetics, corrosion inhibitors, and embalming fluids. Other reported
uses include the production of vaccines.
Exposure
Because formaldehyde is released from so many sources, it is difficult to
assess the amount released into the environment from both direct and indirect
processes. Attempts have been made to estimate exposure levels (Preuss et al.,
1985) from four major types of exposure; ambient air, indoor exposure,
consumer exposure, and occupational exposure (tables l-IV respectively).
These three categories can be condensed by combining ambient air, indoor air,
and consumer exposure into one category, environmental exposure, which
involves exposure outside the workplace. Those exposures occurring in the
workplace will be termed occupational exposure. Tables I, II, and IV indicate the
mean and maximum level in parts per billion (ppb), the number of observations
and the type of exposure. Ambient mean levels range from 0.4 ppb
(background rural) to 24.0 ppb in the Los Angeles Basin during unfavorable
climatic conditions. Possible sources of environmental exposures to
formaldehyde include motor vehicle exhaust, photochemical smog, and the
emissions from burning of gas, oil, coal, and wood (Nelson et al., 1986).
Indoor exposure to formaldehyde concentrations as demonstrated in tables
II and III indicate that off-gassing from both UFFI and pressed-wood products
such as particle board and plywood account for significant routes of exposure.
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Table 11 demonstrates that mean concentration levels rose substantially after
using UFFI in both conventional and nonconventional buildings. In conventional
buildings, the mean concentrations rose from 9-20 ppb, before using UFFI, to
130-280 ppb the first 90 days after using UFFI. The increase is even larger
among nonconventional buildings, citing mean concentration levels of 34 and 46
ppb before installation and 380 and 700 ppb after installation of UFFI (Preuss et
al., 1985).
Occupational exposure is summarized in table IV. There are a number of
populations that appear to be exposed to formaldehyde. The embalming and
funeral service industry has the highest number of people with 2,600,000
exposed at a mean level of 740 ppb. The second largest group of workers
exposed is the textile and apparel manufacturing industry with 800,000 people
exposed to concentrations of a mean level of 250 ppb. While there are only
^'^00 workers estimated in the particle board manufacturing business, the mean
exposure level is the highest at 920 ppb. Other sources with high mean
concentrations include UF foam manufacturing at 740 ppb, with only 50 workers
c/v^wsed, and metalworking machine operations at 500 ppb with 55,000 workers
exposed (Preuss et al., 1985).
Health Effects
There is a wide range of health effects from exposure to formaldehyde either
through the inhalation route or from dermal contact (NAS 1980 Appendix I). In
humans, airborne concentrations as low as 0.1 ppm have been shown to cause
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irritation In the eyes, nose, and throat. Irritation increases as concentrations
increase with severe lacrimation (tearing of the eyes) and pulmonary reactions
such as pnuemonia, bronchial inflammation, and pulmonary edema at airborne
concentrations of 50 ppm. Concentrations of 100 ppm for 30 minutes or longer
are believed to be fatal (CFR 29). Skin irritation is a well documented effect from
dermal contact (Glass 1961, Sneddon 1968). Repeated dermal exposure can
lead people to become sensitized provoking allergic reactions, although even
the most sensitized persons can tolerate up to 30 ppm formaldehyde in
products topically applied (NAS 1981). There are reports of various other types
of health effects on the central nervous system, reproductive system, and blood,
but the end point of primary interest from a regulatory point of view to date has
been carcinogenicity.
The Role of Epidemiology
Epidemiology has played a key role in detecting exposure to carcinogens.
Methods used for assessing risk to humans from exposure to potential
carcinogens should be supported by human data (Clayson et a!., 1985).
However, these studies are of very limited value under certain circumstances.
For substances that have been recently introduced into the commercial market,
the use of epidemiologic studies to determine carcinogenicity would not be
feasible because of the long latency period involved In developing the disease of
interest (Armitage P. 1982). There are several other limitations (U.S. Interagency
Staff Group on Carcinogens (USISGC) 1986) that are difficult to overcome.
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Problems related to hazard evaluation include occupational exposure levels that
are usually at higher levels than the exposure level of interest. Determining
causal relationships at lower concentrations than exposure levels observed,
using extrapolation techniques may produce spurious results. Another problem
arises in determining causality. The USISGC (1986) state that in a strict sense it
is never possible to prove causality. A hypothesis concerning the cause of any
noted increased incidence following exposure may, however, be given evidential
support, based on dose-response relationships, consistency and reproducibility
of results, the strength and specificity of the association, its biological
plausibility, and other considerations. A causal hypothesis can provide
compelling evidence that can lead to preventative action as in the case of
cigarette smoking and lung cancer.
While there are many limitations to using epidemiologic studies in the risk
assessment process, there are many strengths as well. The major strengths
include the studies' abilities to directly assess the risk from environmental
exposure to carcinogens. This in turn may give some insight into the hurhan
carcinogenesis process which allows the extrapolation from exposure to similar
chemicals that have yet to be tested. These studies compliment the data
gathered in long-term animal studies to provide the decisionmaker with the
necessary evidence to make well informed decisions pertaining to the protection
of public health (US Interagency Staff Group on Carcinogens 1986).
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Epidemiologic Evidence
There have been several epidemiologic studies performed on persons
exposed to formaldehyde in occupational settings. A summary of these studies,
as reported by Nelson et al. (1986), is shown in tables V and VI. Table V
documents the mortality of industrial workers from the chemical and garment
industry, while the mortality of professionals such as pathologists, anatomists
and morticians is shown in table VI.
The studies in table V as reported by Nelson et al. (1986), indicate an
increase in mortality for various types of cancer, but lack consistency. An
increase in mortality from lung cancer was seen in two of the six chemical plants,
and one of the three garment plants, while a decrease was observed among
pathologists, anatomists, and morticians. Respiratory cancer was slightly
increased in one of the four garment plants but was below the expected
incidence among pathologists, anatomists, and morticians. There was an
increase in buccal cavity and pharynx cancer in two of the industrial worker
studies, however the authors point out that the industrial studies may be flawed
because of their inability to detect unusual causes of death. Again among the
professionals, there is a defference between the observed and expected values.
An increase in cancer of the lymphopoietic system was reported among the
professionals and garment industry workers, while the six studies of chemical
workers were below those expected. There was a very slight increase in
bladder cancer mortality among both industrial workers and professionals, with
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relative risks of 1.07 and 1.08 respectively. Brain cancer was consistently high
among the studies of professional workers exposed to formaldehyde, but not
among industrial workers.
Overall, the epidemiologic evidence linking cancer with exposure to
formaldehyde is "limited", meaning a causal interpretation is credible (Nelson et
al., 1986). However, comparing different types of cancers among occupationally
exposed workers reveals some inconsistency in the findings of these studies.
Many workers in industrial settings are exposed to other compounds such as
wood dust, a known carcinogen, which may bias the results. Also the exposure
levels are difficult to determine. In the studies listed in tables V and VI, the
author cites a range of mean exposures and the highest level reported. The
mean exposures range from 0.17-3 ppm in the chemical industry studies, with
the highest level reported as 5.4 ppm. The mean exposures range from 0.15 -
8.3 ppm among anatomists, with the highest mean level reported as 14.8 ppm.
A case-control study was performed by Vaughan et al. (1986) in an effort to
determine if an association exists between occupational exposure to
formaldehyde and cancer of the pharynx, or sinus and nasal cavity. Results
from their study indicated that there was no significant association found
between occupational exposure to formaldehyde and the types of cancers they
were scoring. However, the authors admit to several limitations of the study
which tended to conservatively bias the results. j
In a study undertaken by the National Cancer Institute (NCI) in collaboration
with the Formaldehyde Insitute (Fl), Blair et al. (1987) reported the results of the
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largest mortality study of industrial workers exposed to formaldehyde. However,
selection of the cohort was criticized strongly because four of the ten plants used
were studied previously, perhaps indicating that the author had prior knowledge
of the plant population. The cohort consisted of over 25,000 workers who had
been exposed for at least 14 years to formaldehyde. Standard Mortality Ratios
(SMR) were evaluated in relation to dose (an 8 hour TWA > 0.1 ppm). Based
on his analysis, the author concluded that these data provided little evidence that
mortality from cancer was associated with exposure levels of formaldehyde
experienced by the workers studied.
Laboratory Evidence
Long-term animal bioassays to determine the carcinogenicity of chemicals
began in the 1920s. It was not the intent of these early researchers to use this
procedure as a routine method for testing chemicals (Pito, 1981). By the 1960s,
the National Cancer Institute (NCI) had begun large scale testing using
«
standardized protocol (USISGC, 1986). Until this time, there were no uniform
testing procedures. One conclusion drawn from these tests, with the exception
of arsenic, was that known human carcinogens produce tumors in animals in
properly carried out studies. The inverse of that statement, that substances
causing tumors in animals will produce tumors in humans, may not be valid.
Certain chemicals do not produce tumors in all species, but if a chemical has
produced a carcinogenic effect In one species, "in the absence of adequate data
on humans, it is reasonable, for practical purposes, to regard chemicals for
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which there is sufficient evidence of carcinogenicity in animals as if they
presented a carcinogenic risk to humans" (lARC, 1984).
Currently, chronic bioassays are used to determine if exposure to a test
pubstance alters the normal patterns of tumor development (Garth et al., 1986).
Typical National Toxicology Program (NTP) design protocol requires
randomized groups of animals exposed to various treatment levels by some
route of administration. A group of non-exposed animals serve as a control for
comparison. The animals are observed for the majority of their lifetime. Animals
that die before the predetermined end point of the study, or animals that are
killed at interim or terminal sacrifices, undergo necropsy histopathological
examination of organ tissue from various sites. The basic data recorded for
each animal includes the number of days on the study (time of death), necropsy
(gross lesions), and histopathological evaluation, including diagnosis of those
tissues that were examined, and any clinical observations noted during the
course of the study. Statistical analysis is performed to determine the strength
of the evidence of carcinogenicity for that test substance (Garth et al., 1986).'
The biological event of interest is usually the occurrence of a tumor at a
particular organ site. Garth et al. (1986) define a tumor as lesion within a well-
defined class of neoplastic tissue, restricting the group of lesions to tumors of
the same histological type and arising from the the same kind of tissue. While
initially this appears to be a workable definition, many problems arise upon
closer examination. Such outcomes as tumor multiplicity, acceleration of tumor
development in exposed groups and unusual tumor morphology may also be
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carcinogenic responses that require the judgement of an experienced
pathologist.
Table VII, taken from a summary by Flamm et al. (1985) provides the results
of numerous short-term and long-term animal studies. Many of the earlier
studies reported no significant increase in tumor incidence, however, most of
those studies used small numbers (le. 6 rabbits, 10 rats) of animals in each
group or used an exposure route (oral, drinking water) that did not produce a
detectable increase in tumor incidence.
Regulatory agencies, such as OSHA, have stated that the CUT chronic
inhalation study clearly stands out as a superior data set from which to define a
dose-response curve (29 CFR Part 1910). CUT (1981) used two strains of
animals, the Fischer 344 rat and the B6C3F mouse. There were 120 animals of
each sex exposured to 0, 2.0, 5.6, and 14.3 ppm of formaldehyde. The animals
were exposed for 6 hours per day, 5 days per week for up to 24 months. The
scoring of squamous cell carcinoma (SCC) gave the following results when
sexes were combined: for the mouse study, there were 0 tumors at 0, 2.0, and
5.6 ppm, and 2 tumors at 14.3 ppm. In the rat study there were 0 tumors at 0
and 2.0 ppm, 2 tumors (1 male, 1 female) at 5.6 ppm and 103 (51 males and 52
females) developing SCC at 14.3 ppm, yielding a dose-response relationship
(non-linear) only in the rat population at the higher doses (see figure 1). The
concentration dependence in this bioassay has permitted the use of quantitative
risk assessment procedures by regulatory agencies to set exposure limits that
will protect the public health of workers, consumers, and the public at large. The
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CUT study has been used In every formal risk assessment process by the
regulatory agencies to set exposure limits for formaldehyde. A study reported
by Albert et al. (1982), performed at New York University, corroborated CIIT's
results using a different strain of rat, the Sprague-Dawley. Although only one
concentration was used (14.2 ppm), and the length of study was slightly less
than 2 years, a significant increase of nasai tumors was reported.
Results demonstrate a species sensitivity as well as a concentration
dependence. The species difference (at 14.3 ppm there was a 50% tumor
incidence in rats versus 3.3% tumor incidence in B6C3F1 mice), as proposed by
Chang et al. (1982), involves the mouse's ability to reduce minute ventilation so
as to have less formaldehyde available for deposition in the nasal cavity than the
rat. Also, the difference in surface area in the nasal cavity between the mouse
and rrt (the mouse being much smaller) helps to explain the large difference in
tumor incidence rates among the two species.
Both malignant and benign tumors were observed during experiments.
Kerns et al. (1981) reported squamous cell carcinoma (SCC) in 103 rats at a
exposure level of 14.3 ppm. In that same high dose group, three rats developed
polypoid adenomas, a benign tumor. Two of these animals developed SCC.
While the response of the polypoid adenomas was not dose related, there were
some questions by the regulatory agencies as to whether the polypoid
adenomas should be included in the risk assessment. Morgan et al., (1986)
decided to look more precisely at the location of both the squamous cell
carcinomas (SCC) and the polypoid adenomas. Morgan mapped the distribution
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of the SCC and reported that they originated in the mucosa of the anterior nasal
passage and developed from the surface epithelium and not the underlying
glands. This point of origin differs from that of the polypoid adenomas which
originated from poorly ciliated epithelium in the most anterior portion of the nasal
cavity (fig. 2). Also the polypoid adenomas were confined to a small region of
the nasal cavity whereas the SCC were invasive and found in multiple levels of
the nasal cavity. Because of these differences and the fact that the squamous
cell carcinomas are not considered to be the malignant counterpart of the
polypoid adenomas, the data from the benign polypoid adenomas were not
included in the formal risk assessments as proposed by OSHA. However, this
controversy has not been resolved. The USEPA has proposed including the
polypoid adenomas in their risk assessment.
Effects of Treatment
Determining effects on mortality due to exposure of a compound is of
primary interest when analyzing chronic bioassay data (Garth et al., 1986).
Comparing differences in mortality patterns among treatment groups can be
performed using the Kaplan-Meier estimator of the survival function, a step
function defined as follows:
S(t)    =     n
' keR(t)
1
X.,ik
n.,ik
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Suppose that deaths are observed at K distinct times t. , k = 1,2,...K. Suppose
that X.. is the number of animals dying in group i at t. , and n.. Is the number of
animals at risk of dying in group i at t.. For any t, let R(t) = {k: t. ^t}. Another
way of stating It is that R(t) is the set of all k with death times occurring at or
before t. A plot of the survival function S.(t) from beginning to the end of the
experiment compares any effect of treatment on mortality with controls (Garth et
al., 1986). See figure 3 as an example of this method of data treatment. It may
be seen that there is very little effect on mortality at the low dose; however, there
is a substantial effect at the high dose as demonstrated by many earlier deaths
compared with the low dose or control group.
Classically, when using the Kaplan-Meier method for determining the effects
of a compound on mortality, an assumption had to be made was that the tumor
of interest was rapidly fatal. Therefore if an animal developed the tumor, it was
assumed that he died from the tumor. Using context of observation information
allows the investigator to determine whether the animal died from the tumor, or
whether the tumor was an incidental finding at necropsy. Therefore'the
assumption that the tumor was rapidly fatal does not have to be made when
context of observation information is available, demonstrating a more accurate
and realistic effect of treatment on mortality.
Interpretation of data from chronic bioassays is used to determine whether
the treatment also produced a carcinogenic effect. If biases due to
randomization, animal husbandry, and pathological examination are eliminated,
then the effects observed can be attributed to one of three events: 1) chance.
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meaning that each treated individual has the same opportunity as untreated
individuals for developing the outcome 2) differences in the length of time that
each individual v^as at risk of developing the outcome, or 3) the real effects of
treatment. The possibility of chance alone effecting the outcome can be
determined using classical hypothesis testing. Longevity differences can be
corrected so as to eliminate the bias due to intercurrent mortality, leaving only
the effects due to treatment (Peto et al., 1980).
Peto et al. (1980) demonstrated the need to adjust for intercurrent mortality
when analyzing chronic bioassay data. Intercurrent mortality refers to all interim
deaths that are unrelated to the outcome of interest. Previously, investigators
either reported crude proportions of tumor-bearing animals among treatment
groups, or they partially corrected for intercurrent mortality by reporting the
number of tumor-bearing animals as a percentage of the number of survivors
when the tumor was first observed. This does not completely eliminate
intercurrent mortality. If there are similar survival patterns among treatment
groups, then expressing results in this manner may give a reasonably accurate
picture of the effects of treatment. However, if the treatment reduces longevity,
for example through acute toxicity, among different groups, animals may die at a
younger age from this exposure, or other causes, then the treated animals do
not survive a sufficiebt length of time to express the tumor of interest.
Interpretation of the effects of treatment in these studies can have serious
problems.
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For example, consider a chronic bioassay comprised of 200 animals, 100 in
the control group (unexposed) and 100 animals in the exposed group, (exposed
to a chemical). Prior to 12 months, the control group shows 4/40 (10%) of the
1
animals developing a tumor (where the numerator is the number of animals
developing the tumor and the denominator is the number of animals that died)
and the exposed group showed 18/90 or 20% of the animals developing a
tumor. However, after 12 months, the control group demonstrated 21/60 (35%)
and the exposed group demonstrated 7/10 (70%). Regardless of the fact that in
both groups (prior to and after 12 months) the proportion of tumors amongst
survivors was higher in the exposed group than the controls, the total fraction of
animals developing tumors is 25/100 (25%) for both groups (see Table VIII).
This suggest a need to take into consideration the differences in longevity
between the exposed and control groups (Garth et al. 1986).
Table VIII
Control Exposed
Died prior to 12 months 4/40 (10%) 18/90 (20%)
Died after 12 months 21/60(35%) 7/10 (70%)
Total for experiment 25/100(25%) 25/100(25%)
Determining Age-Specific Incidence Rates ;
Chronic bioassays for routine testing of chemicals has become an
increasingly important tool used by regulatory agencies in setting standards for
potential carcinogens. Until recently, however, analysis and interpretation of
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chronic bioassay data have been focused primarily on frequency of tumor
occurrence, neglecting such aspects as time to tumor onset and death, either
from natural causes or as part of scheduled sacrifices. While advances have
been made in the areas of experimental design and pathological evaluation of
long-term animal studies (Gart et al., 1986), statistical methods for determining
age-specific tumor incidence rates remain hampered by the lack of adequate
data. This lack of adequate data is inherently problematic in the approach by
which animal data are collected. Because tumor onset time is not an observable
outcome for occult tumors, age at death with tumor must be substituted, and
statisticians are required to make inferences based on assumptions (ie. the
tumor is rapidly fatal) that may not always represent the real situation.
The use of age-specific incidence rates avoids biases due to the differences
in mortality (Mc Knight 1987) by comparing tumor rates among only those
animals surviving to each age. Determining context of observation for each
individual animal will help to eliminate this bias due to intercurrent mortality.
Context of observation identifies whether the tumor of interest contributed
directly or indirectly to the death of the animal, or alternatively, whether the
tumor was just an incidental finding at necropsy in an animal dying of an
unrelated cause. Because of the unobservable nature of tumor onset time, a
number of different types of time to tumor estimation procedures are presented
in the literature. While a review of these procedures is beyond the scope of this
paper, it is of interest to note that problems exist using each of these estimation
procedures. A parametric approach by Borgan et al. (1984) for estimating tumor
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Incidence was of little value without data from frequent sacrifices. Other
approaches byTurnbull etal. (1978) using sophisticated statistical software
packages to fit log-linear and logistic models to data found it difficult to correlate
the observed differences in the model fits in different groups to the differences
in tumor incidences rates, except in special cases (McKnight and Crowley,
1984). More recently Portier (1986) and Portier and Dinse (1987) have proposed
a semiparametric model which describes the tumor onset rate as parametric in
form, but the death rate is adjusted in a nonparametric fashion and requires
sacrifice information. I
Using information from assigning context of observation is another
approach to determining age-specific tumor incidence rates. Figure 4 is a
schematic of the status of animals in a chronic bioassay study at any specific
time. There are four different possibilities for each animal; 1) alive and not
tumor (ANT), 2) dead and not tumor (DNT), 3) alive with tumor (AT), and 4) dead
with tumor (DT). There are three different conditional death rates; 1) the rate at
which tumor-free animals die without a tumor (X D/NT), 2) the rate at which
tumor-bearing animals die from the tumor (X DFT/T), and 3) the rate at which
tumor-bearing animals die from causes other than the tumor (X DOC/T). The
tumor incidence rate X is the rate at which tumor-free animals develop a tumor.
Because tumor onset is unobservable in occult tumors (tumors that develop in
places that can not be seen, ie. internal organs), it is necessary to include tumor;
prevalence information. Tumor prevalence (p)is defined as the proportion of
those animals alive with tumors, ie. p = AT/(AT-i-ANT). Tumor prevalence can
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be estimated from scheduled sacrifices since at any given time in a large
population the prevalence of tumors among the sacrificed animals should be the
same as the prevalence of tumors in the population. Combining this information
together with context of observation information, and making a few assumptions,
allows the tumor incidence rate to become estimable (Starr 1985).
Tumor prevalence can change with time. Tumor-free animals can develop
tumors or die tumor-free. Tumor-bearing animals can die from the tumor or
from other causes. The rate of change of prevalence with respect to time, dp/dt,
is dependent upon the tumor incidence rate and the natural death rates of both
tumor-free and tumor-bearing animals and can be expressed as follows:
(dp/dt) = (i-p)x^-p(i-p)(x°'^^ + x^O'^^-xD'^
This equation can be solved in terms of the tumor incidence rate by rearranging
to become
X^ = (dp/d.)/(1-p) + p{X°'^/T ^ ^DOC^.^D/NTj
Prevalence information is estimated from frequent scheduled sacrifices,
assuming the prevalence of the tumor in the sacrificed animals is representative
of the prevalence In the population. The three conditional death rates (X ,i
j^DOC/T ^ j^D/NTj   When sacrifice information is not available to estimate
prevalence, the assumption that the presence of a tumor has no effect on the
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risk of dying from other causes, X "      becomes equal to X and these two
terms cancel. When this is true, it has been shown that the prevalence of tumor-
bearing animals dying of natural (nontumor) causes is the same, on average, as
the prevalence rate. That is to say the natural deaths from causes other than the
tumor serve as unscheduled sacrifices and yield information about tumor
prevalence and the rate of change with time (see appendix II for derivation of
formula and complete explanation). Thus the tumor Incidence rate for occult
tumors can now be estimated from the context of observation information (Starr
1985).
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METHODS I
The data used for this study were obtained from the final report issued by
the Chemical Industry Institute of Toxicology (CUT 1981). The 24 month
inhalation toxicity study in male and female mice and rats was initiated in June of
1978 using 120 rodents per sex at exposure concentrations of 0, 2, 6, and 15
ppm for 6 hours per day, 5 days a week for 24 months. There was a post
exposure period of 6 months. Control animals were subjected to the same
procedures asthe treated group, except exposure was to air without
formaldehyde. Body weight, clinical observation, and mortality were monitored
for the length of the study. Because a significant tumor incidence rate (> 50%)
was observed only at the 14.3 ppm level in rats (1% tumor incidence rate at 5.6
ppm in rats), the 14.3 ppm was the only dose group considered in this study:
A record was developed for each animal for the purpose of retrospectively
assigning context of observation (see figure 5). This record contained the
following information: animal number, pathology number, sex, death status
(unscheduled death or sacrifice), and number of days on study. Also Included in
each record were clinical observations, necropsy data (citing gross
abnormalities in organs, cavities, and glands), and histopathology data listing
any abnormal organs,including a diagnosis and a severity rating for any
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abnormal organs. Tumors, (squamous cell carcinomas) were listed as being
present. Each record was reviewed by a pathologist. Dr. Thomas Monticello.
For tumor bearing animals, an initial context (using a four-way classification
system, see below) was assigned based on the information contained in the
record. Histopathological examination of tissue was used in determining the
final context of observation.
Materials used for the histopathology portion of this study were derived
from the same tissue sections and paraffin blocks of the previously reported
chronic inhalation study of formaldehyde in F-344 rats (CUT, 1981; Kerns et al.,
1983). Sections of nasal passages at four representative levels of the nose
(Figure 6) were examined by light microscopy for all rats reported to have
squamous cell carcinomas (Kerns et al., 1983). For each animal, the following
criteria were evaluated as being present or not present (a score of one or zero,
respectively):
i) 50% or more of the nasal cavity occupied by tumor or-the
associated keratin produced by the tumor, at any one level
il) tumor present in more than one level of the nose
iii) tumor invasion
iv) tumor necrosis
v) moderate to severe tumor-associated inflammation
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Based on the results of each case, a four-way classification system was
used In assigning context of observation (ie. whether the cause of death was
directly or Indirectly due to the tumor), as described by Peto (1980):
Context 1 -     Tumor found in animal certainly or almost certainly did not
directly or indirectly cause the animal's death.
Context 2-     Tumor was probably non-fatal to animal (ie. probably
context 1, but not sure).
Context 3 -     Tumor was propably fatal to animal (ie. probably context 4,
but not sure).
Context 4 - Tumor found in animal certainly or almost certainly was
fatal to animal. This category includes both direct causes
of death by the tumor and indirect causes due to some
consequence of the tumor (ie. obstruction of airway, tumor-
induced infection, paraneoplastic effects of tumor).
RESULTS
Table IX list data for each animal. These data include the pathology
number, number of days on study (time of death), sex, context of observation,
tumor status, and death status (sacrifice or unscheduled death).
Table X summarizes the tumor status for all 240 rats exposed to 15 ppm of
formaldehyde. As shown in table X, 103 rats (52 female and 51 males) were
found to be tumor bearing, 121 rats were found to be tumor free and 16 animals
were classified as either missing or critical tissues were not examined. Two of
the five animals listed in the extended unscheduled death category were not
available for nasal turbinate examination, while the three animals that Were
examined in that category were all found to be tumor bearing.
Table XI lists the criteria used to determine context of observation for tumor
bearing animals. Neither of the two animals classified in the definitely incidental
(Dl) context met any of the criteria. Only one of the two animals classified in the
probably incidental (PI) context met one of the criteria. In contrast, six of the
seven animals were scored for two of the criteria in the probably fatal (PF)
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context, and 74 of the 92 animals in the definitely fatal (DF) context met every
criterion. Eighty-eight of the 92 animals in this category had multi-level
involvement and necrosis.
Table XII summarizes the context of observation for all tumor bearing
animals by death times of both unscheduled deaths and sacrificed animals. The
data suggest that squamous cell carcinoma (SCC) is a fatal tumor in rats.
Greater than 97% of the tumors were classified as either definitely fatal (88%) or
probably fatal (9%). As expected, the majority of animals that died unscheduled
deaths from the tumor (definitely fatal) occurred between 12 and 24 months, with
more than half the tumors occurring between 18 and 24 months.
r
Figure 7 illustrates the Kaplan-Meier estimate of survival to death from
tumor, assuming the tumor is rapidly lethal. The first tumor bearing animal died
at day 358, and the last tumor bearing animal died at day 819.
Table XIII lists the data necessary to construct the Kaplan-Meier survival
curve. This includes the number of responses (both positive and negative) and
the number of days on study listed in the order of death times.
DISCUSSION
While assigning context of observation proved to be a simple and efficient
approach used in statistical analysis of bioassay data, pathologists have been
reluctant to perform this task. Results from this study indicate that it is possible
to assign context of observation retrospectively with a high degree of
confidence, and Incorporate this data into the analysis for determining age-
specific tumor incidence rates.
The use of a four way classification system, as suggested by Peto et al.,
(1980) allows the pathologist some latitude in determining whether the tumor of
interest was observed in an incidental or fatal context by using a "probably"
category. This has advantages for both the pathologist and the statistician. If
the pathologist is unsure if the tumor was definitely fatal or definitely incidental,
the pathologist has the option of classifying the tumor as probably fatal or
probably incidental allowing for some degree of uncertainty in cases of multiple
tumors or systemic diseases such as leukemia. The statistician has the option
of reversing the numbers in the probably incidental and probably fatal categories
to determine the effects of misclassification on the outcome. If the numbers in
the "probably" categories are relatively small, then misclassification will likely
have little or no effect on the outcome. Peto et al., (1980) evaluated over 4500
Colworth rats for liver and esophageal tumors using this type of classification
system. Although Peto used a separate category especially for scheduled
sacrifices (context 0), they reported 5.6% of their cases with an uncertain
context. In this study almost 10% of the cases had an uncertain context when
animals used in scheduled sacrifices were included, but less than 4% are of
uncertain context when scheduled sacrifices were not included. The rationale for
including the animals in scheduled sacrifices with the unscheduled deaths is
based on the assumption that the tumor is rapidly lethal, and when a tumor-
bearing animal is sacrificed, the animal actually dies from the sacrifice but would
have died soon after because of the tumor.
These data suggest that nasal tumors can be classified using context of
observation with a high degree of confidence. The validity of this assumption is
illustrated in Table XI which indicates that there were no responses to any of the
criteria in the context definitely incidental and over 90% response to every criteria
in the definitely fatal context. Interestingly, both of the animals that were placed
in the probably incidental context, and 5 of the 7 animals placed in the probably
fatal context, were from scheduled sacrifices and account for almost 90% of
those animals with an "uncertain" context. If the results from the scheduled
sacrifices were not combined as Peto et al., (1980) suggest, then the degree of
certainty of context would be over 98%.
Criteria used to determine context of observation (tumor size, invasiveness,
multi-level involvement, necrosis, and inflammation) were used to reduce much
of the subjectivity that may arise involving the determination of whether a tumor
is incidental or fatal.   Using distinct and well defined criteria for determining
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context of observation allows pathologists the possibility of producing results of
similar quality if data are available.
The Kaplan-Meier estimator of survival to death from fatal tumors is an
appropriate way of visually demonstrating cumulative tumor mortality. The
graph displays the proportion of animals surviving at any given time when all
other causes of death except from the tumor of interest are eliminated. It is
unappropriate to combine both fatal tumors and incidental tumors when using
this graph; therefore context of observation becomes important in determining
only those tumor which were fatal. Usually this curve is used to compare
mortality among treatment groups; however in the case of formaldehyde,
because there were only two tumors in the 5.6 ppm dose, and no tumors in the
2.0 ppm and control group, the results of graphing these doses would be a
horizontal straight line at 1.0 (except for a slight downward dip to account for the
two tumors found at terminal sacrifice at the 5.6 ppm treatment level). Graphing
the low dose and control groups would show insignificant effects due to
treatment. !
^eto et al., (1980) used information from context of observation to analyze
his data from 4500 Colworth rats (16 treatment groups) exposed to N-
nitrosodimethylamine (NOMA), Using the same categories as previously
described (Contexts 1-4), Peto reported 42% of the tumors were classified as
either definitely incidental (39%) or probably incidental (3%), and 58% as either
definitely fatal (55%) or probably fatal (3%). Because nearly half of the tumors
found were classified as either definitely incidental or probably incidental, Peto
35
used two different methods to analyze his data to eliminate the bias due to
intercurrent mortality. For those rats in context 1 and 2 (definitely/probably
incidental), Peto used the 'prevalence' method. For those animals in context 3
and 4 (definitely/probably fatal), he used the 'death rate' method. He discovered
that if the 'prevalence' method had been applied to both the incidental tumors
and fatal tumors, misleading inferences would have resulted, demonstrating a
protective effect of NOMA. Conversely, if he used the 'death rate' method for
both fatal and incidental tumors, he found a highly significant carcinogenic effect.
This clearly demonstrates the need to eliminate the bias due to intercurrent
mortality. However, in the case of formaldehyde, because greater than 97% of
the tumors (SCC) were classified as either definitely fatal or probably fatal, using
the "death rate" method would be appropriate for analyzing those tumors
classified as definitely or probably fatal, while the remaining 3% of the incidental
tumors should be analyzed using the prevalence method to avoid introducing
bias.
CONCLUSIONS
There is a high degree of confidence (greater than 90%) that animals with tumors
can be readily classified with a context of observation.
\
Squamous Cell Carcinoma was probably/definitely fatal to rats exposed to 14.3
ppm formaldehyde in 97% of the cases, and therefore an analysis based on the
assumption that the tumor was rapidly lethal would not be expected to produce
much bias.
It is oyident that this classification can be done in a retrospective mode, long
after the bioassay has been completed, provided that the information has been
properly archived.
Age-specific tumor incidence rates can be estimated using scheduled sacrifice
and context of observation information.
i
Context of observation information provides a simple and efficient approach to
making inferences concerning age-specific tumor incidence rates. This
information helps to eliminate potential bias due to intercurrent mortality among
treatment groups.
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This type of data also adds a new dimension to risl< characterization by focusing
attention on the time to tumor onset in addition to the probability of developing a
tumor.
RECOMMENDATIONS
Carefully selected criteria to determine context of observation should be used to
reduce much of the subjectivity that might arise when pathologists attempt to
classify the tumor as incidental or fatal.
Investigators should properly archive all the information so retrospective analysis
can be performed without loss of accuracy over time.
It is apparent from this study and from Peto's work that both nasal tumors and
internal organ tumors can be classified with a high degree of confidence.
Pathologists should be encouraged to determine context of observation both
retrospectively and as the study is on-going.
More emphasis should be placed on time-dependent aspects of carcinogenesis
bioassays. Comparing age-specific tumor incidence rates is a much more
effective methods for determining effects from treatment.
More work needs to be done in quantaitative modeling field to accommodate
time-to-tumor data that will allow regulatory agencies to focus on more than just
the cumulative lifetime probability of developing cancer.
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Change the terminology of context of observation to something that is
understandable to most people. Recommendations include cause of death
assignment, tumor context, or tumor lethality.
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Table I. Anbient FormaldAyit Levels
Type ef ExpotuTt
UtttnheroJ •
Ohtenationt*
Espoture Levd (ppb)
Utan
Rural areas (background)*
Eniwetok Atoll. South Pacific 7Urban areas'
Los Angeles Basin (typical) 27Los Angeles Basin (severe inversion) 65Biyonne. N.J. NRCamden. N.J. NRElizabeth, N.J. NRNewark, N.J. NR
0.4
Max. •
0.8
8.0 12.0
S4.0 48.0
6.1 20.0
3.8 14.0
5.5 16.0
6.6 20.0
•NR indicates not reported.
^Estimated number expoaed: 60,000,000'Estimated number expoaed  *     "'^ ~^Souree: Adapted bom Re£. ^fe^g^et al.,   (1985)
Table II . Indoor Exposure to Fonnaldehyde
Sampling
and Mean
Analytical Number oj ConcentrationSouTtt oj Exposure Methods' Observations Levels (ppb)
Canadian UFFl Study
Homes with health complaints CA 100 139Control (non-UFFI) homes CA 378 34UFFI homes (no complaints) CA 654 40UFFI homes (no complaints) CA 1146 54United Kingdom UFFI Study
Control (non-UFFI) buildings MBTH-CA 50 47UFFI buildings MBTH-CA 1143 93Buildings before-after UFFI
Conventional (double-wall
masonry) before MBTH-CA 7 20-9.0Conventional (double-wall
masonry) after MBTH-CA 7 130-280'-Nonconventional (prefab
concrete) before MBTH-CA 2 46,34"^Nonconventional (prefab
concrete) after MBTH-CA 2 380, 700"
*CA is chromotropic acid and MBTH is 3-methyl-2-benzothiazoIone hydrazone.*Averiges over first 90 days postinstailation.'Averages of two houses prior to insiallaUon.
'Averages of tlte (wo houses measured prior to iastallatioD over Ciist 90 days postinstallalion. /.nCTr\Source: Adapted from Befa   PreuSS   et   al. ,    (1965)
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Table x\Oocupationa] Exponire to Formalddiyde
Exponire
Estimated Number 0J Leod{ppb)
Number Obter-   •
Erpoture Source Exposed ttetiont Mem Max.
Direct mfr. of formaldehyde 1400 135 410 2200
Resin mfr. (VF. PF)
Plywood m: r. (UF. FF)
6000 8 240 490
S7,000 81 350 1200
Particle board mfr. 4000 6 920 1400
Wood furniture mfr. eo,ooo 6 100 140Mobile home mfr. 32.000 _ _ _
UP foam mfr. 50 4 740 1280
UFFI installation 1000 17 420 1300
Metal molds-castings mfr. 60,000 11 390 690
Plastic products mfr. 17.000 8 350 500Paper and paperboard mfr. 1000 64 470 990
Textile and apparel mfr. 800.000 30 250 310
Building paper and building board mfr. 4000 — .m. _
Paints and coatings mfr. 2300 — _ __
Abrasive products mfr. 7000 — — w
A;sbestos products mfr. .— — — ^
Nonresin CHO derivatives mfr. £50 _ _ .»
Nitrogenous fertilizers mfr.
Use (rf CHtO-containing saniution
3000 1 500 500
products — 2 380 470Use in agricultural pesticide
applications
Biology-medical laboratories
_ 12 320 650
— — —
Embalming and funeral aervice
industry 2,600.000 6 740 1390
Metalworldng machine operations 55,000 9 500 1200
Norrc: — indiott« dau not avaHabie.
Source: preuss et al.,   (1985)
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Table V - Formaldehyde exposure: mortality of chemical and garment workers.
Q.z\i?.e of
Obserxed/expectcd (0/E) deaths
Chemical industrj- Garment industrv*
Toul Totaldeath Al A2 A3 A4 AS          AC AW) B(SS) CWS) DW) E(^ Tim A-F 0/E'All causes 77/93 9A'107 49/45 e45'as3 104/149  446/485 1619/18C2 115/—* 24/—' 146/197 256/—* 1765.-2059 0.8GAll cancers 19/23 32/27 la'll 251/246 21138     114/123 455/46S 20/22 10/6 37/37 42/27 87/73 651/633 1.03Skin 2/— 01— 1A).9 2/1.1 3/2.0 __Buccal cav.
and phar.
Respirator)-
5/4.6 2/0.2 3/1.3 10/6.1 1.64
6/7.5 3/2.3 12/12.4 11/12.2 32/34.4 0.93Nose 0/0.05 0/0.06 0/0.03 0A).5C 0/0.09     0,-0.28 0/1.07 0/— 0>— 0/— 0/— 0/— O/l.I —LarxTix 4'4.5 lA- 0/— 4/4.5 —Lung 6/9.3 11/11.5 7/4.7 12S^I03.4 7/13.3    46/31.6 205/193.8 11/11.7 1&7.6 11/11.6 245/224.7 1.09Digestive n&'117 8/6.3 *n.h 6/9.5 14i9.0 22a7.5 171/160.8 1.06Esophagus 01— 1/0.9 1/0.9 —Colon 4«.6 3«.0 7/3.6 1.94Prostate 0/— 4/1.3 4/1.3 —Kidney 7/8.3 0/— 1/1.0 8«.3 0.86• BUdder
Brain
18/16.9
6/12.5
0/—
0/—
1/0.8
30.6 l«.l
19/17.7
6/16.2
1-07
0.56. 20/26.3 2/2.3 IA>.5 6/4.4 &Z.S 10/6.1 44/42.1 1.03Lrmphopoietic
Leukemia 9/11.4 2a.7 4/2.4 15/15.5 0.97
'Range of mean exposures, 0.17-3 ppm; no. of camples > 142; highest level reported, 5.4 ppm.* Range of mean exposures, 0.7-0.74 ppm; no. of samples, 85; highest level reported, 2.7 ppm.*0/E given only when observed and/or uqieeted deaths » 5.'Proportional moriility study.
Source: Nelson et al., (1986)
Table  VI      Formaldehyde exposure: Mortality •fpatholofista, anatomists, and morticians (includes combined totals of observed andexpected deaths for Tables 1 and 2).
Observed/expected (0/E) deaths
Pathologist*
Gl            G2
Anatociust* Mortician' Total Table
Total
si and 2
11 12 KCause of death {99,100) {99J00) H(»«) U01J02) aoj.ioi) J (/OJ) UOiJOS) L(iOtf) Total G-L 0/E* A-L . 0/E*All causes 146/244 110/195 737/1129 1132/-* wnt—' 319/322 833/—* 31A-* 1312/1890 0.69 8077/3949 0.78All cancers 38/62 82/52 120/188 243/219 205^70 68^7 69/60 17/13 772/83J 0.93 14230464 0.97Skin 2/3.5 8/3.6* 2/3.4 <VD.9 Ot- V— 12ai.4 I.OS 1503.4 l.'l2Buccal cav. 1/6.8 8^.1 8«.l l«.l S/1.6 01— 21/23.7 0.89 31/29.8 1.04and phar. -
•
Respiratory- 13/46.3 74/70.7 43/46.0 20/21.6 13/17.3 4/3.7 167/205.5 0.81 199/239.9 0.83. Nose <W).l 0/0.4 0A).5 0/0.6 on.i 0/— Oa.8 _ 0/2.9 __Larynx 1/2.8 2/3.4 2«.6 (W.O u- 6^.8 0.61 10/14.3 0.70Lung 10/27.4 9/22.0 12/43.0 78/66.8 41/42.8 19120.2 12^4.0 3/3.4 17&239.6 0.74 423/464.3 0.91Digestive 12/19.8 8/15.5 88/66.4 68/65.2 6S/31.0 17/22.6 1&/19.3 V4.2 233/270.0 0.86 404/430.8 0.94Esophagus 2/4.6 6/5.3 SM.1 on.7 in.3 OA- 11/17.0 0.65 1207.9 0.67Colon 20/18.5 29/20.3 ViTliM 5/S.4 in.4 85/61.6t 1.38 92/65.2t 1.41ProsUte 20/18.7 15/16.4 tim.v 30.4 &«.8 3A.5 69/59.9 1.15 73/61.2 1.19Kidney 1/4.0 8/5.4 ma 1/1.7 1/1.4 01— 16/16.5 0.97 24/25.8 0.93Bladder \fZ.\ 2/1.9 5^.2 7/7.3 8/5.8 6/2.5 01— 29/26.8 4.08 4S/44.5 I.OSBrain V1.2* 10/3.7t 9/5.8 9/4.7 3/2.6 1/1.6 01— 36/19.6* 1.84 45/35.8 1.26Lymphopoetic 8/3.8* m.o 18/14.4 25«0.6 19/15.6 8/6.5 10/5.6 l/l.l 91/70.6* 1.29 135/112.7* 1.20Leukemia 1/1.5 1/1.1 10/6.7 12/8.5 12/6.9 4/2.5 8/2.6t 48,-29.8! 1.61 63/45.3* 1.39
'Range of mean exposures, 0.16—4.8 ppm; no. of samples, 78; highest level reported, 13.57 ppm.^Range oftaetn exposures. 0.15-8.3 ppm; no. of samples, 32; highest level reported, 14.8 ppm.'Range of mean exposures, 0.74-2.7 ppm; no. of samples, 200, highest level reported, 5.26 ppm.*0/E given only when observed and/or expected deaths » 5.•Proportional mortality study.
•Significant increase, p < 0.05.
f Significant increase, p < 0.01.
  Significant increase, p < 0.001.Source:  Nelson et al.,   (1986)
W.G  ftAMM & V. FRANKOS
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Table yjjtudies ot the carcinogenicity of formaldet»yde in laboratory animals
Species Mo  •»«tmali cc' Co«npound Aou^e •«« t9r>gm el ttuOl Twntow mcia»nct
9'oup •no eose Ireouencv
Ral 10 t ml o( 0 4% for¬ Subcutaneous 15 months 2/10 local
malin once/week sarcomas
1/10 liver
1/10 peritoneal
cavity
Rat 20 1 ml ot 9-40% Subcutaneous Until tumour 7/20 local
HMT* once/week formation sarcomas
Rat (BO) 15/sex 0. 0.4 g HMT
(total dose)
Oral, drinking-
water
333 days Negative
Mouse (CTM . 27-100/sex 0. 0.5. 1.0. Oral, drinking- 110-130 weeks Negative
SWR.C3HF) 5.0% HMT water
Rat 12-4B/sex 0. 1.0. 5.0% HMT Oral, drinking- 156 weeks Negative
(Wistar) water
Rat 12-24/sex 0. 1.0% HMT Oral, drinking- 3 generations Negative
(Wistar) water lor
20^0 weeks
Rat 16-4S/sex 0. 2.0% HMT Oral, drinking- 2 years Negative
(Wistar) water (or
50 weeks
Rabbit 6 0, 3y. lormalin Direct applica¬
tion to palate
5 times/week
10 months 1/6 'carcinoma
in situ of the
palate
Mouse 42-60/group 0.41.80, 163 ppm inhalation 35-70 weeks Negative
(C3H) tormaidehyde 1 h/day
3 days/week
Hamster 88-132 0. 10 ppm Inhalation LMetime Negative
(Syrian males formaldehyde 5 h/day
poiden) 3 days/week
fta"> 120/sex 0,2.0.5.6.14.3 ppiT Inhalation 2.5 years Nasal tumours
(Fischer formaldehyde 6 h/day (combined
344) 5 days/week sexes.
103/200 at
14.3 ppm. 2/214
•t 5.6 ppm)
Mouse 120/sex 0,2.0.5 6.14.3 ppm Inhalatiort 2.5 years Nasal tumours
(B5C3F,) lormaldehyde 6 h/day
5 days/week
(2/240 at
14.3 ppm)
Ra: 100 males 0. 14.7 ppm Inhalation Lifetime Nasal tumours
(Sprague- formaldehyde 6 h/day (25/99)
Oawley) + 10.6 ppm HCI 5 days/week
Ral 100 males 0, 14.3 ppm lnhalatio(\ 586 days* Nasal tumours
(Sprague- formaldehyde 6 h/day (12/100)
Oawley) + 10.0 ppm HCl 5 days/week
Rat 100 males 0, 14.1 ppm Inhalation 5Bfl days* Nasal tumours
(Sprague- formaldehyde 6 h/day (6/100)
Dawley) + 9.5 ppm HCl 5 days'«««k
Rat 100 males 0. 14.2 ppm Inhatation SBSdays* Nasal tumours
(Sprague- formaldehyde 6 h/day (10/100)
Dawiey) 5 days.<week
•MMT. Htttmtn^y<tntltutm,nt   tofmi tormataetirOC upon Bit»wpo»»»»"
 mwf.rr fctu'ls
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TIME TO TUMOR STATISTICS
PATH # DAYS      SEX
1 801581
2 801587
3 801651
4 801569
5 801641
6 801628
7 801583
8 801650
9 801595
10 801636
11 801653
12 801797
13 801761
14 801701
15 801728
16 801776
17 801700
18 801690
19 801717
20 801693
21 801748
22 801762
23 801656
24 801719
25 801627
26 801767
27 801754
28 801763
29 801711
30 801639
31 801646
32 801585
33 801676
34 801643
35 801601
36 801596
37 801602
38 801619
39 801664
40 801766
5 M
181 M
181 M
181 M
181 M
181 M
181 M
181 M
181 M
181 M
181 M
181 F
181 F
181 F
181 F
181 F
181 F
181 F
181 F
181 F
181 F
252 F
274 M
319 F
353 M
353 F
358 F
361 F
364 F
364 M
364 M
364 M
364 M
364 M
364 M
364 M
364 M
364 M
364 M
364 M
)B        TUMOR DEATH   —
1            0 UD
1             0 6 MO SAC
1            0 6 MO SAC
1              0 6 MO SAC
10 6 MO SAC
1            0 6 MO SAC
1            0 6 MO SAC
1            0 6 MO SAC
1             0 6 MO SAC
10 6 MO SAC
1           0 6 MO SAC
10 6 MO SAC
1            0 6 MO SAC
1            0 6 MO SAC
10 6 MO SAC
1             0 6 MO SAC
1            0 6 MO SAC
1              0 6 MO SAC
10 6 MO SAC
1             0 6 MO SAC
1             0 6 MO SAC
1             0 UD
1             0 UD
1              0 UD
1             0 UD
1             0 UD
4             1 UD
1            0 UD
4              1 UD
1             0 12 MO SAC
1            0 12 MO SAC
1              0 12 MO SAC
1             0 12 MO SAC
1             0 12 MO SAC
1              0 12 MO SAC
1             0 12 MO SAC
1            0 12 MO SAC
1             0 12 MO SAC
1             0 12 MO SAC
1             0 12 MO SAC
PATH # = PATHOLOGY NUMBER
DAYS = DAYS ON STUDY
COB = CONTEXT OF OBSERVATION
TUMOR = 1=PRESENT    0=ABSENT
DEATH = UD=UNSCHEDULED DEATH
MO SAC=MONTH OF INTERIM SACRIFICE
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TIME TO TUMOR STATISTICS (CONT)
PATH # DAYS      SEX COB        TUMOR       DEATH
10 12 MO
1 0 12 MO
1 0 12 MO
1 0 12 MO
10 12 MO
1 0 12 MO
1 0 12 MO
1 0 12 MO
1 0 12 MO
10 UD
4 1 UD
4 1 UD
4 1 UD
10 UD
4 1 UD
4 1 UD
1 0 UD
4 1 UD
4 1 UD
4 1 UD
4 1 UD
1 0 UD
4             1 UD
2 0 UD
4 1 UD
10 UD
4 1 UD
4 1 UD
4 1 UD
1 0 UD
4 1 UD
10 UD
4 1 UD
1 0 UD
4 1 UD
4 1 UD
4 1 UD
10 UD
4 1 UD
4             1 UD
PATH # = PATHOLOGY NUMBER
DAYS = DAYS ON STUDY
COB = CONTEXT OF OBSERVATION
TUMOR = 1=PRESENT    0=ABSENT
DEATH = UD=UNSCHEDULED DEATH
MO SAC = MONTH OF INTERIM SACRIFICE
41 801791
42 801777
43 801751
44 801774
45 801720
46 801746
47 801684
48 801787
49 801765
50 801617
51 801710
52 801640
53 801659
54 801771
55 801745
56 801610
57 801796
58 801633
59 801741
60 801740
61 801638
62 801604
63 801655
64 801715
65 801725
66 801785
67 801642
68 801792
69 801736
70 801567
71 801772
72 801677
73 801574
74 801729
75 801775
76 801708
77 801697
78 801652
79 801618
80 801742
364 F
364 F
364 F
364 F
364 F
364 F
364 F
364 F
364 F
390 M
420 F
432 M
432 M
433 F
438 F
474 M
477 F
479 M
479 F
488 F
491 M
495 M
504 M
504 F
508 F
509 F
511 M
512 F
520 F
521 M
525 F
530 M
531 M
531 F
633 F
533 F
535 F
537 M
539 M
543 F
SAC
SAC
SAC
SAC
SAC
SAC
SAC
SAC
SAC
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TIME TO TUMOR STATISTICS (CONT)
PATH # DAYS SEX COB TUMOR DEATH ™
121 801734 552 F 0 18 MO SAC
122 801794 552 F 0 18 MO SAC
122 801780 552 F 0 18 MO SAC
124 801783 552 F 1 18 MO SAC
125 801577 555 M 0 UD
126 801667 560 M 1 UD
127 801749 567 F 1 UD
128 801558 569 M 1 UD
129 801706 571 F 0 UD
130 801688 572 F 1 UD
131 801609 674 M 1 UD
132 801621 574 F 1 UD
133 801670 574 M 0 UD
134 801722 - 577 M 0 UD
135 801658 677 M 0 UD
136 801795 683 F 0 UD
137 801766 586 F 0 UD
138 801564 588 M UD
139 801699 588 F UD
140 801707 590 F UD
141 801698 595 F UD
142 801723 596 F UD
143 801685 596 F UD
144 801799 603 F UD
145 801597 606 M UD
i^« ?01579 607 M UD
147 801582 609 M UD
148 801629 614 M UD
^. ͣi.a ouxioO 615 F UD
150 801592 619 M UD
151 801599 619 M UD
1 c;'> 801714 620 F UD
lOO OKJXfjZb 621 M UD
154 801709 624 F UD
155 801757 627 F UD
156 801781 629 F J - UD
157 801622 630 M UD
': -^oa 631 M UD
159 801666 631 M UD
160 801687 631 F 0 UD
PATH # = PATHOLOGY NUMBER
DAYS = DAYS ON STUDY
COB = CONTEXT OF OBSERVATION
TUMOR = 1=PRESENT    0=ABSENT
DEATH = UD=UNSCHEDULED DEATH
MO SAC=MONTH OF INTERIM SAC
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TABLE X
CHARACTERIZATION OF RATS EXPOSED TO FORMALDEHYDE
ATISPPM
Time to
death in
TUMOR BEARING TUMOR FREE
NASAL TURBINATES
NOT EXAMINED ANIMALS MISSING
months
M F TOTAL M F TOTAL M F TOTAL M F TOTAL TOTAL
6 0 0 0 10 10 20 0 0 0 0 0 0 20
12 0 0 0 10 10 20 0 0 0 0 0 0 20
18 4 4 8 15 15 30 1 0 1 0 0 0 39
24 3 7 10 10 7 17 0 0 0 0 0 0 27
27 2 0 2 3 0 3 0 0 0 0 0 0 5
U.D.* 39 41 80 13 18 31 1 4 5 4 4 8 124
Ext. U.D.* 3 0 3 0 0 0 1 0 1 1 0 1 5
TOTAL 51 52 103 61 60 121 3 4 7 5 4 9 240
UD = unscheduled deaths.
Ext. UD = extended unscheduled deaths.
TABLE XI
CONTEXT OF OBSERVATION IN TUMOR-BEARING ANIMALS
Total Number
with Context
Number of Animals with each Criterion
Context Tumor SizeI 50%
Involvement of
more than one
level
invasion Necrosis Inflammation
Definitely Incidental (Dl)
Probably Incidental (PI)
Probably Fatal (PF)
Definitely Fatal (DF)
2
^    ''1
91
0
0
0
88
0
4
90
0
0
0
81
0
0
5
90
0
1
6
84
Total # of Tumor-Bearing
Animals 103
Histopathological criteria as described in text.
O)
TABLE XII
CONTEXT OF OBSERVATION OF TUMOR-BEARING ANIMALS
BY TIME OF DEATH (MONTHS) FOR UNSCHEDULED
DEATHS AND SCHEDULED SACRIFICES
CONTEXT 12 18 24 27 Subtotal Total
Definitely Incidental
unscheduled deaths
sacrificed
0
0
0
0
0
0
1
0
0
1
1
1
Probably incidental
unscheduled deaths
sacrificed
0
0
0
0
0
0
0
1
0
0
0
1
Probably fatal
unscheduled deaths
sacrificed
0
0
0
0
0
5
2
1
0
1
2
7
Definitely fatal
unscheduled deaths
sacrificed
0
0
2 23 52 3
0 4 7 0
80
11
91
Total 32 64 103
TABLE Xm
KAPLAN-MEIER TUMOR FREE SURVIVAL CURVE
RP RN RT
58
1 0 1 5
2 0 1 181
3 0 1 252
4 0 1 274
5 0 1 319
6 0 2 353
7 1 0 358
8 0 1 361
9 1 20 364
10 0 1 390
11 1 0 420
12 2 0 432
13 0 1 433
14 1 0 438
15 1 0 474
16 0 1 477
17 2 0 479
18 1 0 488
19 1 0 491
20 0 1 495
21 1 1 504
22 1 0 508
23 0 1 509
24 1 0 511
25 1 1 512
26 1 0 520
27 0 1 521
28 1 0 525
29 0 1 530
30 1 1 531
31 2 0 533
32 1 0 535
33 0 1 537
34 1 0 539
35 1 0 543
36 2 1 545
RP = RESPONSE POSITIVE
RN - RESPONSE NEGATIVE
RT = RESPONSE TIME IN DAYS
59
KAPLAN-MEIER SURVIVAL CURVE (CONT)
RP RN RT
37 0 1 546
38 3 6 547
39 1 9 550
40 3 12 551
41 2 4 552
42 0 1 555
43 1 0 560
44 1 0 567
45 1 0 569
46 0 1 571
47 1 0 572
48 2 1 574
49 0 2 577
50 0 1 583
51 0 1 586
52 2 0 588
53 0 1 590
54 1 0 595
55 2 0 596
56 0 603
57 0 606
58 0 607
59 0 609
60 0 614
61 0 615
62 2 619
63 0 620
64 0 621
65 0 624
66 0 627
67 0 1 629
68 1 0 630
69 2 1 631
70 0 1 633
71 0 1 641
72 1 0 642
RP = RESPONSE POSITIVE
RN = RESPONSE NEGATIVE
RT = RESPONSE TIME IN DAYS
60
KAPLAN-MEIER TUMOR FREE SURVIVAL CURVE (CONT)
RP RN RT
73 1 0 643
74 0 1 644
75 1 1 652
76 1 0 654
77 1 0 663
78 1 0 665
79 1 0 672
80 2 0 673
81 0 1 675
82 0 1 679
83 1 0 683
84 2 1 686
85 0 1 687
86 1 0 688
87 1 1 689
88 1 0 693
89 1 0 694
90 1 0 697
91 1 0 697
92 1 0 699
93 2 0 705
94 0 2 705
95 1 0 711
96 1 0 712
97 1 0 715
98 1 0 718
99 1 1 721
100 3 0 727
101 7 0 728
102 4 9 729
103 0 1 740
104 1 0 753
105 1 0 767
106 0 1 808
107 1 0 812
108 2 3 819
RP = RESPONSE POSITIVE
RN = RESPONSE NEGATIVE
RT = RESPONSE TIME IN DAYS
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FIG.   1
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Fic. 2 Diagram of Lrvtl II of the ni note ihowini the
mn of attachment (fine Unn) of polypoid adenomas and
the number of nu with a polypoid idenoma at each site
The bold linev indicated b> the arrowv iho» the principal
met, of origin of the majoritv of squamous cell carcinomas
(tee Tabic I and Figs 3 and 3). N > Basottrbinate.^cIT
• 0;axilloiurbm«ie. S • aasal lepium.
Source:  Morgan et al.,   (1986)
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Fig.   3   Kaplan-Meter estimates of survival curves for three groups of female mice (D.
control; O, low dose; A, high dose) treated with 1^-dich(oroethane
100       110      120
Time (weeks)
Source: Garth et al., (1986)
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ANT X D/NT DMT
AT
X DFT/T
X DOC/T
Fig- A
DT
Schematic of bioassay animal status at any specific time.
Animals are either alive and tumor-free (A^^^), dead without
tumor (DNT), alive and tumor present (AT), or dead with
tumor present (DT). As time passes, tumor free (ANT)
animals can develop tumors at a rate of X (tumor
incidence rate) or die tumor free at a rate X D/NT.
Tumor-bearing (AT) animals can die from tumor or from
other causes at rates X DFT/T or X DOC/T respectively.
Source: Starr, (1985)
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Fig.5
Pathology Number: 801757
Animal Number: 2303
TYPICAL RECORD
Sex: F
Status: UD
Days on Study: 627
# of Slides: 16
# of Blocks: 4
Histopathology
Organ
Colon A
Adrenal Gland A
Pituitary Gland A
Bone Marow-Femur A
Lymph-node Mandibular A
Spleen A
Nasal Turbinate A
Diagnosis
Nematodiasis P
Zonal Fasciculata Lipicosis
Bilateral   2
Pars Distalis Adenoma P
Hyperplasia 3
Lymphocytic and plasmacytic
hyperplasia diffuse 3
Lymphoid Depletion 2
Epithelial Dysplasia Multifocal 2
Hyperkeratosis focal 3
Olafactory epithelium squamous
metaplasia multifocal 2
Rhinitis seropurulent 2
Squamous cell carcinoma P
Squamous metaplasia multifocal 2
Necropsy
Nasal Cavity
Pituitary
mass
enlarged and/or cystic focal or
diffuse
Clinical Observations
From Date To Date Abnormal Observations
800212 800229 Nasal/Occular Discharge
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800302 800303 Nasal/Occular Discharge
800302 800303
Context: 4
Red Eyelids
Comments
FIG.  6
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A —NASOTURBINATES
B - MAXrLLOTURBINATES
C — ETHMOTURBINATES
Mdtagma! Mcinn or I r«f hMd that dwnorMstw t« kft*WH ti*i
I fldnw t\ MCti lrv« {/KV)toi trntmuj^ik, vvakjMor..
Source:  Kerns et al.,   (1983)
igure 7  liap I ar-Me i ir Estimates of Tumor FreeSurvival
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APPENDIX l'
Table 1» Summary of Selected Animal Acute-Inhalation Data on Formaldehyde
Duration
Species Concentration, ppn of Exposure
Rflt 820 0.5 h
482 4 h
250 4 h
Cat 650-1,600 8 & 4 h
735 2 h
650 4 h
Effecta
300 3.5 h
LCjQ (over 3 wka)
Death In 2-4 of 6
Death, pulmonary edema,
emphysema
Death
Irritation, recovery
in 6 d
Irritation, recovery
in hours
Reference
Skog, 1950
Nagornyl jet jbI. , 1979
Carpenter et  al.,1949
Iwanoff, 1911
Iwanoff, 1911
Iwanoff, 1911
Iwanoff, 1911
Guinea pig
Mouse
0.3-50
414
3.1
1 h
4 h
10 mln
Increased airway
resistance, decreased
lung compliance
LC 50
RD50
Amdur, 1960
Nagornyl, et al., 1979
Kane and Alarle, 1977
Table 2. Summary of Effects of Prolonged ExposuwFto Formaldehyde in Animals
Duration
Concentration,ppm of Exposure
41.5, 83
50
1 h/d, 3 d/wk
X 35 wk
5 h/d, 1 d/wk
X 18 mo
Species
Mouse
Effects
Hyperplasia and metaplasia of the
tracheal epithelium
Hamster Squamous cell metaplasia
Reference
Horton et al, 1963
Netteshelra,  1976
15*
15*
12.7
10
6 h/d, 5 d/wk
lifetime
6 h/d, 5 d/wk
lifetime
6 h/d, 5 d/wk
X 13 wk
5 h/d, 5 d/wk
T<  18 mo
Rat     Squamous cell carcinomas in the naso¬
maxillary epitheliura, epithelial
dysplasia and squamous cell meta¬
plasia of nasal turbinates
Mouse   None to date
Mouse,  Nasal irritation, decreased body
rat     weight
Hamster Cell proliferation, hyperplasia
CUT, 1979b;
CUT, 1980
CUT, 1979b;
CUT, 1980
Battelle Columbus
Laboratories,
1977a
Netteaheim, 1976
6*
6*
4.6
60 d Rat
6 h/d,   5  d/wk        Rat
lifetime
6 h/d,   5 d/wk
lifetime
45 d
6 h/d, 5 d/wk
X 13 wk
Respiratory tract and eye irritation,
decreased body weight, decreased
number of alveolar macrophages
Squamous cell carcinoma of skin
in 1 rat, epithelial dysplasia and
squamous cell metaplasia of nasal
turbinates
Mouse   None to date
Rat     Yellowing of body hair, decreased
body weight
Mouse,  None observed
rat
Dubreull et  aj[.,
1976
CUT, 1979b;
CUT, 1980
CUT, 1979b;
CUT, 1980
Dubreull et al,,
1976
Battelle Columbus
Laboratories,
1977a
o
|Table 2. (continued)
Concentration,  Duration
ppm_________   of Exposure  Species Effects
3.8
0.0098
90 d
2.4 90 d Rat
2* 6 h/d, 5 d/wk
lifetime
Rat
2* 6 h/d,  5 d/wk
lifetime
Mouse
1.6 90 d Rat
0.82 90 d Rat
0.028 90 d   ? Rat
90 d
Rat, rabbit,  1 of 15 rats died, some inflam-
dog, monkey,  matlon of lungs in all species
guinea pig
Peribronchial and perivascular
hyperemia
Epithelial dysplasia and squamous
cell metaplasia of the nasal
turbinates
None to date
Rat
Yellovring of body hair
Peribronchial and perivascular
hyperemia
None observed
None observed
Reference
Coon £t al^.,
1970
Fel'dman and Bon-
ashevskaya, 1971
CUT, 1979b,
CUT, 1980
CUT, 1979b,
CUT, 1980
Dubreull eX  al.,
1976
Fel'dman and Bon-
ashevskaya, 1971
Fel'dman and Bon-
ashevskaya, 1971
Fel'dman and Bon-
ashevskaya, 1971
 Study in progress; only Interim findings have been reported.
Table 3. Summary Of Human Inhal^Pon Data on Formaldehyde
Concentration, ppm
20
13.8
0.5-10
6-5
0,67-4.82
0.02-4.15
0.9-2.7
0.3-2.7
0.03-2.5
Exposure
Chamber
(< 1 mln)
Chamber
(30 min)
Indoor resi¬
dential air
Occupational
(10-30 min)
Indoor resi¬
dential air
(Infants)
Indoor resi¬
dential air
Occupational
Occupational
Indoor resi¬
dential air
Effects
Discomfort, lacrimation
Eye and nose irritation
Eye irritation, headaches,
GI tract symptoms,
skin problems, respiratory
complaints
Irritation, discomfort,
lacrimation
Vomiting, diarrhea,
lacrimation
Reference
Barnes and Speicher, 1942
Sim and Pattle, 1957
Sardinas et  al., 1979
Fassett, 1963
Wisconsin Division
of Health, 1978
Eye and upper respiratory    Wisconsin Division
tract irritation, headache,   of Health, 1978
tiredness, nausea, diarrhea
Upper respiratory tract irri- Blejer and Miller, 1966
tation, lacrimation
Annoying odor, lacrimation,   Shipkovltz, 1968
irritation of respiratory
tract, disturbed sleep
Drowsiness, nausea, headache, Breysse, 1977
nose and respiratory tract
irritation
Table 3. (continued)
Concentration, ppm Exposure Effects Reference
0.9-1.6 Occupational intense eye Irritation and
Itching; dry, sore throat;
Increased thirst; disturbed
sleep
Merrill, 1961
0.25-1.39 Occupational Upper respiratory tract
Irritation, coughing,
headaches
Kerfoot and Mooney,
1975
O.A-0.8 Occupational Lowered FEVj^ q/FVC, upper
respiratory tract
Irritation
Shoenberg and Mitchell,
1975
0.13-0.45 Occupational Burning and stinging of eyes,
nose, and throat; headache
Bourne and Sefaflan,
1959
-4
CO
Table 4  Sutntna y of Clinical Studies with Formaldehyde
Duratlor Z  of SubjectsConcentration, ppu of Expo; re No- Subjects   Responding Effects Reference
0.03-3.2*
0.03-2.1*
0.42
0.25
35 mln
20 mln
1.6 5 h/d
X 4 d
0.83 5 h/d
X 4 d
0.03-0.5* 5 mln
5 h/d
X 4 d
5 h/d
X 4 d
33
33
16
16
33
16
16
45
36
19
33
20
10
7
94
94
11
3
2
31
19
No significant change In eye
blinking rate
Doubling of eye blinking rate
Increases In eye blinking rate
Doubling of eye blinking rate
"Desire to leave the room"
Medium eye Irritation
Strong odor, strong eye Irritation
"Slight discomfort," conjunctival
Irritation, dryness of nose
and throat
"Slight discomfort," conjunctival
irritation, dryness of nose
and throat
Doubling of eye blinking rate
"Desire to leave the room"
Medium eye irritation
"Slight discomfort," conjunctival
irritation, dryness of nose
and throat
"Slight discomfort," conjunctival
Irritation, dryness of nose
and throat
*Total exposure for 35 mln at concentrations increasing from 0.03 to 3.2 ppm.
^Andersen, 1979
''Weber-Tschopp et al., 1977 4^
Table 5« Summary of Irritation Thresholds' (33 Subjects Exposed
to Formaldehyde at 0.3-3*2 ppm for 35 mln)
Response Threshold Concentration
Throat Irritation
Eye blinking rate
Eye irritation
Nose irritation
"Desire to leave the room"
2.1 ppm
1*7 ppm
1.2 ppm
1.2 ppm
1.2 ppm
*Weber-T8chopp et al., 1977
en
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Appendix II
lr~~^—Li
2
3)      dNgW ^ ^^N^(^)  .  (^^ ^ X4)N3(t)
dt i 4    3
SOLUTIONS:
1)      N^(t)  = Nj e'^^1 * V*
2) —31—       11^'        11"31
NgCt)  s J    XjNje'^l * V* dt   n!
o
X,       (i-«-P^i*V*)
(Xj   Xg)
-1-
77
3)      dN  (t) ^ ^^^^(^j  _  (^^ ^ X^)N3(t)
^^^3^^^     (X3 * X^)N3(t) = XjNjCt)d'b
= X^N^ e-C^l * V*
,(t)e(^3 * V*   = f e(S * V* X^N, e'^^ * V* dt .
XX r e^'s V^4 - H - ^-2)^ dt
XjN^  (e^^S * ^4 " ^2 ' V* - 1)
(X3   X^ - Xj - Xg)
^      "-----------------(X3   X^ - Xj - Xg)--------------
4)      dN.ft)
^t =  (X3 * X^)N3(t)
(X3 * x^) \/^ {f^-^h   V r- e - (^3 * V*)
(X3   X^ - Xj^ - Xg)      _.
' (X3 * X, - X, - X^)      ^
dt
(X3 ^ X^)X^N^
(X3   X^ - X^ - Xj) ^^1*^2)        ------------(X3   X^)
-2-
78
SUMMARY:
1)
2)
NjCt)
No(t) Xj (1 - • - (H * V)
3)      N,(t)
(A3 4 x^ - ^1 - ^2
4)      N^(t) = (X      X^)XgN (1 - e-C^l - V^)
(Aj   Xg)
(1 - e-(^3 * ^4)*)
Some other definitions:
P(t) =N3(t)/[Nj(t)   N3(t)]
^!!3i^^   [N.(t) ^NgCt)]
dP(t) ^      fi^
[N^(t)    N3(t)]2
dNj(t)        dNgCt)
dt ^t
N,(t)
[N^(t)    NgCt)]^
dN3(t)   ^                       dN^(t)
ni A j^-------     "3^t "3r
[Nj(t) = H^it)f        [N^(t)    N3(t)]2
_ Nj(t)  dN3(t)/dt
[NjCt)  * NjCt)!^
PdN^(t)/dt
[Nj(t)       NgCt)]
-3-
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NjCt)
_______________= 1 - P
[NjCt)    NgCt)]
dP(t) ^ (l-P)dN3(t)/dt)    _ PdNj(t)/dt
dt [Nj(t)     NgCt)] [N^(t)     NgCt)]
_ (1-P) dN3(t)/dt - PdNj(t)/dt)
[N^(t)   NgCt)]
dP(t)    _    (1 - P(t))   (XgNjCt) - (X3   X^)N3(t))
-3t-     ---------------(H^(t) * NgW)-------------------
^     P(t)   (X2   Xg) N^(t)
CNj(t)    NgCt))
Dropping the explicit time reference.
dP ^ (1 - P) (XgN^ - (X3   X^)N3)
^ ('Jl *  H3)
^  P (Xj   Xg) Nj
sXjd - P) (1 - P) - (1 - P) (X3 + X^)P
  P (X^   Xg) (1-P)
**P = XjCl - P) (1 - P)   P(l - P) (Xj   Xg - X3 - X^)
-4-
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solving for X^:
but this requires that X., X^ and X^ be estimable from the data.  (P and dP/dt
may be estimated from the sacrifice data).
By looking at the animals dying with a tumor, we may find the fraction dying in
any interval from the tumor and the fraction dying from other causes. Let f. be
the fraction of animals dying with £ tumor who die from the tumor.
then f, »   ^3
or XgfJ   X^fJ = X3
Vi = ^3 - Vi = ^3(1 - V
X^ = XgCl  -  f j)/fj
Also, we might assume that the presence of a tumor does not affect the rate of
u&ci;.ri ^Aj Irom all other causes. In other words:
Riif we irpnw thsit the rate at which animals are dying free of a tumor is
Rj = XjNj
The total rate of dying, R, is:
R=Rl   (X3*X4)N3
but also, X^ s XgCl - fi)/fi
-5-
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• R s R^   X3(l   (1 - f^)/iy)tiy
\ (R - RJor A, s_____^    V_______^   {1   (1 - \)/\)^s
. X   _   <JP/dt  ^    (R - R-)P
[1 - P]     [l  ^^ ~ ^l^^N 3
1
^ dP/dt  ^     (R - R „3
[1 - P]   [ 1 ^ ^' ' ^M h^S ' V
or
X =  dP/dt  ^ (R - Rj)
[1 - P]    [ 1   ^^ ' ^1^ ] fN^ *'h )3
1
To summarize, finding X^ requires:
P = fraction of tiving animals with a tumor in the "sacrifice" group.
__|_ = Rate of change of P during some small increment of time.
dt
R = total rate at which the animals are dying in the "non-sacraf ice" group'v
R. = Rate at which animals are dying free of a tumor.
f- = fraction of animals dying with a tumor who are judged to have died from the
tumor,
P and dP/dt come from the "sacrafice" group. R, R. and f- come from the "non-
sacrafice" group.
